125 related articles for article (PubMed ID: 10706176)
1. New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances.
Hunfeld KP; Kraiczy P; Wichelhaus TA; Schäfer V; Brade V
Eur J Clin Microbiol Infect Dis; 2000 Jan; 19(1):27-32. PubMed ID: 10706176
[TBL] [Abstract][Full Text] [Related]
2. Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates.
Hunfeld KP; Kraiczy P; Wichelhaus TA; Schäfer V; Brade V
Int J Antimicrob Agents; 2000 Jun; 15(1):11-7. PubMed ID: 10856671
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi.
Kraiczy P; Weigand J; Wichelhaus TA; Heisig P; Backes H; Schäfer V; Acker G; Brade V; Hunfeld KP
Antimicrob Agents Chemother; 2001 Sep; 45(9):2486-94. PubMed ID: 11502519
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility testing of four antibiotics against Borrelia burgdorferi: a comparison of results for the three genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi sensu stricto.
Sicklinger M; Wienecke R; Neubert U
J Clin Microbiol; 2003 Apr; 41(4):1791-3. PubMed ID: 12682190
[TBL] [Abstract][Full Text] [Related]
5. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies.
Dever LL; Jorgensen JH; Barbour AG
J Clin Microbiol; 1992 Oct; 30(10):2692-7. PubMed ID: 1400969
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics.
Baradaran-Dilmaghani R; Stanek G
Infection; 1996; 24(1):60-3. PubMed ID: 8852472
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.
Caol S; Divers T; Crisman M; Chang YF
BMC Vet Res; 2017 Sep; 13(1):293. PubMed ID: 28962614
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Borrelia afzelii strains to antimicrobial agents.
Ruzić-Sabljić E; Podreka T; Maraspin V; Strle F
Int J Antimicrob Agents; 2005 Jun; 25(6):474-8. PubMed ID: 15871918
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy.
Hunfeld KP; Ruzic-Sabljic E; Norris DE; Kraiczy P; Strle F
Antimicrob Agents Chemother; 2005 Apr; 49(4):1294-301. PubMed ID: 15793100
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi.
Hunfeld KP; Weigand J; Wichelhaus TA; Kekoukh E; Kraiczy P; Brade V
Int J Antimicrob Agents; 2001 Mar; 17(3):203-8. PubMed ID: 11282265
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values.
Boerner J; Failing K; Wittenbrink MM
Zentralbl Bakteriol; 1995 Nov; 283(1):49-60. PubMed ID: 9810645
[TBL] [Abstract][Full Text] [Related]
12.
Koetsveld J; Manger A; Hoornstra D; Draga RO; Oei A; Kolyasnikova NM; Toporkova MG; Sarksyan DS; Wagemakers A; Platonov AE; Hovius JW
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661882
[No Abstract] [Full Text] [Related]
13. In vitro activities of faropenem, ertapenem, imipenem and meropenem against Borrelia burgdorferi s.l.
Rödel R; Freyer A; Bittner T; Schäfer V; Hunfeld KP
Int J Antimicrob Agents; 2007 Jul; 30(1):83-6. PubMed ID: 17512703
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of Borrelia and Leptospira to Quinupristin-dalfopristin (Synercid) in vitro.
Murgia R; Cinco M
New Microbiol; 2001 Apr; 24(2):193-6. PubMed ID: 11346304
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of European human Borrelia burgdorferi sensu stricto strains to antimicrobial agents.
Veinović G; Cerar T; Strle F; Lotrič-Furlan S; Maraspin V; Cimperman J; Ružić-Sabljić E
Int J Antimicrob Agents; 2013 Mar; 41(3):288-91. PubMed ID: 23312603
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of the everninomicin SCH 27899 and other newer antimicrobial agents against Borrelia burgdorferi.
Dever LL; Torigian CV; Barbour AG
Antimicrob Agents Chemother; 1999 Jul; 43(7):1773-5. PubMed ID: 10390242
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.
Dever LL; Jorgensen JH; Barbour AG
Antimicrob Agents Chemother; 1993 May; 37(5):1115-21. PubMed ID: 8517700
[TBL] [Abstract][Full Text] [Related]
18. [Borrelia burgdorferi Group: in-vitro antibiotic sensitivity].
Henneberg JP; Neubert U
Orv Hetil; 2002 May; 143(21):1195-8. PubMed ID: 12073540
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi.
Yang X; Nguyen A; Qiu D; Luft BJ
J Antimicrob Chemother; 2009 Apr; 63(4):709-12. PubMed ID: 19182236
[TBL] [Abstract][Full Text] [Related]
20. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
